Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Whittaker

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunctionStephen P East, Samantha Bamford, Matthias G A Dietz, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chainStephen J Davies, Andrew P Ayscough, R Paul Beckett, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZLloyd G Czaplewski, Ian Collins, E Andrew Boyd, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Cancer Research Communications|March 27, 2023
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer ImmunotherapyMichael R Paillasse, Michael Esquerré, Florie A Bertrand, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunctionStephen P East, Samantha Bamford, Matthias G A Dietz, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chainStephen J Davies, Andrew P Ayscough, R Paul Beckett, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZLloyd G Czaplewski, Ian Collins, E Andrew Boyd, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Cancer Research Communications|March 27, 2023
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer ImmunotherapyMichael R Paillasse, Michael Esquerré, Florie A Bertrand, et al.
Pageof 5